A new version of ResearchHub is available.Try it now
Paper
0
IDDF2024-ABS-0270 Efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: primary endpoint results from a phase 2b open-label, randomized, multicenter study MYR204
Authors
Jianwei Yu,Tarik Asselah
Pietro Lampertico,Jacobus Bosch,Adrian Streinu-Cercel,Victor Pântea,Ştefan Lazăr,Gheorghe Plăcintă,George Gherlan,Pavel Bogomolov,Tatyana Stepanova,Viacheslav Morozov,Vladimir Chulanov,V. Syutkin,Olga Sagalova,В. Городин,Dmitry Manuilov,Renée-Claude Mercier,Lei Ye,John Flaherty,Anu Osinusi,Audrey Lau,Ben Da,Marc Bourlière,Vlad Ratziu,Stanislas Pol,Marie‐Noëlle Hilleret,Fabien Zoulim
+26 authors
,В.Н. ГородинPublished
Aug 1, 2024
Posted by
Save
Tip0
TipSave
